methysergide

(redirected from Sansert)
Also found in: Medical.

methysergide

(ˌmɛθɪˈsɜːdʒaɪd)
n
(Pharmacology) a drug, C21H27N3O2, used in the form of its maleate to prevent migraines
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
Methysergide (Sansert) is contraindicated but is not available in United States.
(Sansert) propranolol 80-480 mg/day ABORTIVE THERAPY DRUG COST/DOSE [*] 100% oxygen NA [**] sumatriptan $43.30 (Imitrex) $18.28 dihydroergotamine $12.65 $8.10 butorphanol nasal $2.68 spray (Stadol NS) PREVENTIVE THERAPY prednisone $0.36 (60 mg/day) verapamil $1.04 (80 mg q.i.d.) lithium carbonate $0.24 valproic acid $0.72 (250 mg b.i.d.) methysergide $6.06 (Sansert) (2 mg t.i.d.) propranolol $0.72 (240 mg/day) ABORTIVE THERAPY DRUG COMMENT 100% oxygen Must administer through a mask, not a cannula.
Selective antagonists of 5-[HT.sub.2A] receptors are ketanserin and MDL100907; nonspecific agents include methysergide (Sansert) and d-LSD.[44] These agents produce increased slow wave sleep,[29] facilitation of circulation[58] and therapeutic effects on dysthymia and the negative symptoms of schizophrenia.[31,33] 5-[HT.sub.2A] receptors are also found on platelets and are involved in vascular contraction, as well as platelet shape changes and aggregation.[44]